DURHAM – BioAgilytix Labs is continuing to grow through acquisition, announcing Wednesday evening its second acquisition this week.
Joining the fast-growing life science firm is MicroConstants, which is based in San Diego. Earlier this week the company disclosed it is buying Australia based 360biolabds.
BioAgilytix already is growing its Triangle workforce with a planned addition of more than 800 jobs and an investment of $61.5 million.
MicroConstants is a contract research organization.
Financial terms were not disclosed.
Noted Jim Datin,CEO of BioAgilytix: “We believe that by joining forces, BioAgilytix and MicroConstants will not only create significant scientific and performance synergies, but also we are better able to serve the growing biotechnology community on the West Coast. Most importantly, our customers and their patients will benefit from the leading-edge science the combined company will bring to market.”
MicroConstants China is not part of the deal, BioAgilytix said.
